Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murali Varma

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
BMJ (Clinical Research Ed.)|October 11, 2018
Low risk cancer: recalibrate rather than just rename?Murali Varma
Advances in Anatomic Pathology|May 15, 2021
Intraductal Carcinoma of the Prostate: A Guide for the Practicing PathologistMurali Varma
Histopathology|August 26, 2025
Urothelial carcinoma reporting: more grade categories improve risk stratificationMurali Varma
The American Journal of Surgical Pathology|October 10, 2018
Gleason Grading: There Is No Substitute for JudgmentMurali Varma
Histopathology|June 29, 2017
Low-grade intraductal carcinoma of the prostate: an idea whose time has not yet comeMurali Varma
BMJ (Clinical Research Ed.)|August 12, 2021
When staging becomes screening: public education is the keyMurali Varma, Krishna Narahari
Journal of Clinical Pathology|July 19, 2022
Clinical utility of histopathology data: urological cancersMurali Varma, Sean Williamson
BMJ (Clinical Research Ed.)|August 28, 2012
Potential sources of overdiagnosis in histopathologyMurali Varma, Varsha Shah
Journal of Clinical Pathology|June 14, 2024
Authors' reply: megablocks are nice but not really necessaryMurali Varma, John Dormer
Journal of Clinical Pathology|February 8, 2017
A snake in the grassRhiannon Trefor, Murali Varma
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
BMJ (Clinical Research Ed.)|October 11, 2018
Low risk cancer: recalibrate rather than just rename?Murali Varma
Advances in Anatomic Pathology|May 15, 2021
Intraductal Carcinoma of the Prostate: A Guide for the Practicing PathologistMurali Varma
Histopathology|August 26, 2025
Urothelial carcinoma reporting: more grade categories improve risk stratificationMurali Varma
The American Journal of Surgical Pathology|October 10, 2018
Gleason Grading: There Is No Substitute for JudgmentMurali Varma
Histopathology|June 29, 2017
Low-grade intraductal carcinoma of the prostate: an idea whose time has not yet comeMurali Varma
BMJ (Clinical Research Ed.)|August 12, 2021
When staging becomes screening: public education is the keyMurali Varma, Krishna Narahari
Journal of Clinical Pathology|July 19, 2022
Clinical utility of histopathology data: urological cancersMurali Varma, Sean Williamson
BMJ (Clinical Research Ed.)|August 28, 2012
Potential sources of overdiagnosis in histopathologyMurali Varma, Varsha Shah
Journal of Clinical Pathology|June 14, 2024
Authors' reply: megablocks are nice but not really necessaryMurali Varma, John Dormer
Journal of Clinical Pathology|February 8, 2017
A snake in the grassRhiannon Trefor, Murali Varma
Pageof 11